Could HIV drugs help clear psoriasis? tiny study explores the idea
NCT ID NCT04274595
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small study tested whether a short course of HIV drugs (emtricitabine and tenofovir) could reduce inflammation in people with plaque psoriasis. Only 8 people took part, and the main goal was to see changes in certain markers in skin biopsies. The study is complete, but results are not yet clear. Much larger studies would be needed to know if this approach really works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- emtricitabine and tenofovir (HIV drugs)
- What this could lead to
- If it works, this could point toward a new treatment option for psoriasis by targeting inflammation at the cellular level.
- What could go wrong
- This was a very small, early study with only 8 people and no clear results. The drugs are not approved for psoriasis and may have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Montpellier
Montpellier, 34295, France
-
CHU de Nimes
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new gel calm psoriasis Flare-Ups?
- Can a Once-Daily cream tame psoriasis in toddlers?
- Can a switch to guselkumab clear stubborn psoriasis?
- Can a new biologic clear stubborn psoriasis?
- Diet and exercise may tame psoriasis in kids — a trial puts it to the test
- Ancient herbal mix put to the test against psoriasis